Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-25-170077
Filing Date
2025-07-31
Accepted
2025-07-31 07:34:42
Documents
6
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 6-K d48779d6k.htm 6-K 8605
2 EX-99.1 d48779dex991.htm EX-99.1 24815
3 EX-99.2 d48779dex992.htm EX-99.2 17141
4 GRAPHIC g48779g0730220735399.jpg GRAPHIC 2601
5 GRAPHIC g48779g0730221053698.jpg GRAPHIC 2601
6 GRAPHIC g48779g0731001059118.jpg GRAPHIC 1087
  Complete submission text file 0001193125-25-170077.txt   60900
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 251169440
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)